Dear Colleagues,
I’m pleased to share a concise analysis of the polio situation in Angola drawing on WUENIC 2024 coverage estimates, 2025 evolution and insights from IMB 2025 report. Feedback and additional insights from the TechNet community are most welcome.
Angola has already surpassed its 2024 cVDPV2 case count, with broader geographic spread and persistent immunity gaps.
What’s driving the surge?
Why it matters
-Low IPV1/IPV2 and Pol3 coverage sustain risk.
-MCV1–MCV2 gaps mirror deeper system weaknesses in second-year-of-life services and defaulter tracing.
Response on the ground
Two nOPV2 rounds were completed in Aug–Sep 2025. Sustained impact now hinges on:
✅ SIA quality
✅ On-schedule IPV1/IPV2 and Pol3 delivery
✅ Targeted mop-ups in low-coverage areas
✅ Cross-border coordination
Program benchmark
Interrupt transmission within 120 days of outbreak notification (quality and timeliness of rounds remain critical).
What to watch next
-Fewer unlinked cases
-Declining environmental detections
-Improving administrative coverage, with later confirmation via WUENIC
For the full write-up and Angola WUENIC trendlines, see this week’s @ImmunizationForResilienceNewsletter at https://www.linkedin.com/pulse/angola-polio-complexity-2025-routine-immunization-tambe-tw6me
I have also attached the PDF file.
I welcome reflections on operational best practices, especially around IPV delivery in cVDPV2 outbreaks, second-dose measles performance, and cross-border synchronization.
I’m in India for an Advanced Vaccinology Conference at Christian Medical College Vellore. It will be graced by polio champion Dr. Ananda Bandyopadhyay. A privilege to learn and exchange insights. Thank you, and stay tuned!
With appreciation,
Tambe Elvis Akem
Medical Field Epidemiologist | Health & Immunization Specialist
@ImmunizationForResilienceNewsletter